AIM ImmunoTech Inc. Cash And Cash Equivalents At Carrying Value

• AIM ImmunoTech Inc. showed an increase of +75.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), AIM ImmunoTech Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 51.2%.
• Historical annual values: Fiscal year 2025: $2.99 million | Fiscal year 2024: $1.70 million | Fiscal year 2023: $5.44 million | Fiscal year 2022: $27.05 million | Fiscal year 2021: $32.09 million | Fiscal year 2020: $38.50 million | Fiscal year 2019: $1.47 million | Fiscal year 2018: $299.0 thousand | Fiscal year 2017: $1.41 million | Fiscal year 2016: $2.41 million | Fiscal year 2015: $2.12 million | Fiscal year 2014: $2.16 million | Fiscal year 2013: $803.0 thousand | Fiscal year 2012: $2.21 million | Fiscal year 2011: $3.10 million | Fiscal year 2010: $2.92 million | Fiscal year 2009: $58.07 million | Fiscal year 2008: $6.12 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026